Redmile Group, LLC
Redmile Group, LLC's open-market purchases and sales year by year since 2006, and every transaction reported to the SEC on Form 4: date, shares, price and a…
Insider buying and selling since 2019
Redmile Group, LLC bought shares on the open market in 2019, 2020, 2021, 2022, 2023 and 2024, and has not bought since 2024 across 8 companies. Sales in 3 of the 8 years since 2019.
Redmile Group, LLC reported 14 open-market purchases and 11 sales since 2019; purchases in 6 different years, most recently 2024.
| Year | Bought | Sold |
|---|---|---|
| 2026 | — | 6×6 trades |
| 2024 | 6×6 trades | 3×3 trades |
| 2023 | 1×1 trade | — |
| 2022 | 1×1 trade | — |
| 2021 | 4×4 trades | — |
| 2020 | 1×1 trade | 2×2 trades |
| 2019 | 1×1 trade | — |
Insider at 8 companies
- Adc Therapeutics Sa ADCT2024–2026 · 4 purchases, 7 sales
- Fate Therapeutics FATE2020–2024 · 4 purchases, 1 sale
- Shattuck Labs STTK2024 · 1 purchase, 1 sale
- Zymeworks ZYME2022 · 1 purchase, 0 sales
- Entrada Therapeutics TRDA2021 · 1 purchase, 0 sales
- Absci ABSI2021 · 1 purchase, 0 sales
- Invivyd IVVD2021 · 1 purchase, 0 sales
- Aprea Therapeutics APRE2019–2020 · 1 purchase, 2 sales
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. The amounts, the people and every filing are in OQRO Pro.
Trades disclosed
Latest trade
Largest trade
Companies
Every disclosed trade
Every trade this person has disclosed
Newest first, each one linked to the filing it came from.
Already a member? Sign in
What this page holds
- Every disclosed trade, newest first
- How purchases did after they were reported
- Companies and committees involved
- A link to every official filing
What OQRO is
OQRO reads the public record for US-listed companies — insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings, and federal contract awards — and puts each one in plain words next to the filing it came from. It describes what was disclosed. It does not give investment advice or tell you what to buy.
Want to see real filings before you pay? The home page shows live ones, free, with the link to each source document.
Questions about Redmile Group, LLC's trades
Has Redmile Group, LLC bought shares on the open market?
Redmile Group, LLC bought shares on the open market in 2019, 2020, 2021, 2022, 2023 and 2024, and has not bought since 2024 across 8 companies. Sales in 3 of the 8 years since 2019.
When did Redmile Group, LLC last buy or sell shares?
In SEC filings since 2019: the latest open-market purchase is from 2024; the latest open-market sale is from 2026.
Which companies has Redmile Group, LLC traded as an insider?
8 companies: Adc Therapeutics Sa (ADCT, 2024–2026), Fate Therapeutics (FATE, 2020–2024), Shattuck Labs (STTK, 2024), Zymeworks (ZYME, 2022), Entrada Therapeutics (TRDA, 2021) and others.